Cervical shortening is when the cervix, the narrow lower portion of the uterus that opens into the vaginal canal, becomes shorter than expected during pregnancy. A cervix measuring 25 millimeters or less before 24 weeks of gestation is clinically considered short, and this finding is associated with a six-fold increase in the risk of preterm delivery. Outside of pregnancy, cervical shortening isn’t a medical concern; it becomes significant because a shorter cervix may not be strong enough to hold a pregnancy to term.
How the Cervix Normally Changes in Pregnancy
During a healthy pregnancy, the cervix stays long, firm, and closed for most of the nine months. It acts as a structural barrier between the uterus and the outside world, held together largely by tightly organized collagen fibers. Circumferential collagen in the middle layer of the cervix is especially important for resisting dilation.
As a pregnancy approaches full term, the cervix gradually softens and shortens through a process called cervical remodeling. This is a normal part of the body preparing for labor. The collagen breaks down, the tissue becomes more pliable, and the cervix thins and opens to allow delivery. When this same process kicks in too early, well before the baby is ready to be born, it becomes a problem. Research has identified premature cervical remodeling as one of the key drivers of preterm birth, with inflammatory responses playing a particularly large role when infection is involved.
Why It Happens
Cervical shortening in the second trimester can stem from several different causes, and sometimes more than one is at play. The most common categories include:
- Infection or inflammation inside the uterus. Intra-amniotic infection and sterile inflammation (an inflammatory response without detectable bacteria) are among the most significant causes and tend to carry a worse prognosis.
- Previous cervical or uterine surgery. Procedures like a LEEP (loop electrosurgical excision), cone biopsy, dilation and curettage, or hysteroscopy can remove or damage cervical tissue, weakening its structural integrity in future pregnancies.
- Uterine overdistension. Carrying twins or higher-order multiples stretches the uterus beyond what a single pregnancy would, placing extra mechanical pressure on the cervix.
- Congenital uterine differences. Structural variations like a septate or arcuate uterus can affect how the cervix functions during pregnancy.
- Connective tissue disorders. Genetic conditions such as Ehlers-Danlos syndrome and Marfan syndrome affect collagen throughout the body, including in the cervix, making it more vulnerable to premature shortening.
- Decidual hemorrhage. Bleeding at the interface between the placenta and uterine wall can trigger inflammatory changes that lead to cervical remodeling.
Symptoms Are Usually Absent
One of the tricky things about cervical shortening is that it typically produces no obvious symptoms. By definition, cervical insufficiency is either asymptomatic or associated with only mild, nonspecific signs: a feeling of pelvic pressure, low backache, a slight increase in vaginal discharge, or light spotting. These symptoms overlap with so many normal pregnancy discomforts that they rarely raise alarm on their own, which is why screening with ultrasound is the primary way cervical shortening gets detected.
How It’s Measured
Transvaginal ultrasound is the standard tool for measuring cervical length. It’s preferred over an abdominal ultrasound or a manual exam because cervical shortening starts at the internal opening (the end closest to the baby) and progresses downward. By the time a clinician can feel the change during a physical exam, significant shortening may have already occurred. On ultrasound, shortening is visible much earlier.
The measurement is straightforward: the ultrasound probe is placed in the vaginal canal and the full length of the cervical canal is measured in millimeters. A length of 25 mm or less before 24 weeks of gestation falls at roughly the 2nd to 3rd percentile for that stage of pregnancy and meets the clinical threshold for a short cervix.
Who Gets Screened
Professional guidelines from ACOG and the Society for Maternal-Fetal Medicine recommend that women with a prior spontaneous preterm birth undergo serial cervical length measurements every one to two weeks, starting at 16 weeks and continuing through 24 weeks. For women carrying a single baby who have no history of preterm birth, universal screening is not formally mandated but is considered reasonable, and many practitioners do offer it. Routine screening in multiple pregnancies (twins, triplets) is not currently recommended by these organizations, partly because the management options differ and the evidence is less clear.
Vaginal Progesterone
For women with a singleton pregnancy and a short cervix found between 18 and 24 weeks, daily vaginal progesterone is one of the best-studied interventions. Progesterone helps maintain the cervix by counteracting the inflammatory and biochemical processes that drive premature remodeling.
The numbers are encouraging. In pooled analyses, vaginal progesterone reduced the risk of delivering before 33 weeks from about 22% to 14%, a 38% relative reduction. The benefits extended across multiple gestational thresholds: a 35% reduction in delivery before 34 weeks and a 28% reduction before 35 weeks. Current evidence supports a daily dose of 90 to 100 mg, which is the lowest dose shown to be effective. Treatment typically begins when the short cervix is identified (between 18 and 24 weeks) and continues through 36 weeks.
Cervical Cerclage
Cerclage is a surgical procedure in which a stitch is placed around the cervix to reinforce it. There are two main scenarios where it’s used. A history-indicated cerclage is placed early in pregnancy (often around 12 to 14 weeks) for women who have had previous second-trimester losses or very early preterm births. An ultrasound-indicated cerclage is placed when a cervical length of 25 mm or less is found before 24 weeks, typically in women who also have a relevant obstetric history.
A third, more urgent type is sometimes called an emergency or rescue cerclage, placed when the cervix is already found to be dilated or when membranes are bulging through the opening. This carries higher risks but can still extend a pregnancy significantly.
In a 10-year retrospective study from a tertiary center, the median gestational age at delivery was 38.4 weeks for history-indicated cerclage and 38.3 weeks for ultrasound-indicated cerclage, both essentially full term. Miscarriage rates were low in both groups (3.4% and 2.1%), and rates of delivery before 34 weeks were 11.2% and 14.9% respectively. These results suggest that when cerclage is placed for appropriate indications, the majority of pregnancies reach a safe gestational age.
Cervical Pessary
A cervical pessary is a silicone device placed around the cervix that works by changing the angle between the cervix and uterus, tilting the cervix posteriorly so that the weight of the pregnancy is redistributed away from the cervical opening. The most commonly studied version is the Arabin pessary, developed in Germany in the late 1970s.
The main appeal of a pessary is that it’s noninvasive. It can be inserted and removed in a clinic visit without anesthesia, and it’s significantly less expensive than surgical cerclage. Some comparative analyses have found that cervical pessary, vaginal progesterone, and cerclage have similar effectiveness in women with a singleton pregnancy, a history of preterm birth, and a short cervix. However, at least one randomized controlled trial found that pessaries did not reduce preterm delivery before 34 weeks when used preventively. The evidence remains mixed, and pessary use varies widely between clinics. It’s most often considered when a patient or provider prefers to avoid surgery, or when cerclage is not feasible.
What Cervical Shortening Means for Your Pregnancy
Finding out you have a short cervix can feel alarming, but it’s worth understanding that a short measurement is a risk factor, not a guarantee of preterm birth. Many women with a cervical length under 25 mm go on to deliver at or near their due date, especially with appropriate management. The earlier the shortening is detected and the shorter the measurement, the higher the risk, which is why early screening matters for those with known risk factors.
Management is typically tailored based on your specific situation: whether you’re carrying one baby or more, your obstetric history, how short the cervix is, and how far along the pregnancy is. In many cases, vaginal progesterone alone is sufficient. In others, cerclage or a pessary may be added. Your care team may also increase the frequency of ultrasound monitoring to track whether the cervix is stable or continuing to shorten, which helps guide decisions about escalating treatment.

